Results 181 to 190 of about 70,470 (286)
Comparative analysis of plasma BNP and NT-proBNP levels, and NT-proBNP/BNP ratio in patients with chronic kidney disease. [PDF]
Fujii H, Goto S.
europepmc +1 more source
NT‑proBNP: a biomarker with new potential application [PDF]
openaire +2 more sources
Targeting Arterial Dysfunction in Cardiovascular Disease Using Stem Cell‐Based Therapies
Graphical presentation of stem cell‐based therapies for arterial dysfunction, endothelial repair and regeneration strategies. SMC, smooth muscle cell. ABSTRACT Arterial regeneration represents a critical frontier in cardiovascular medicine, as progressive endothelial dysfunction, maladaptive vascular smooth muscle cell (SMC) plasticity, and chronic ...
Yun‐Yu Ma, Shu‐Yao Zhu, Yi Song
wiley +1 more source
ABSTRACT Background Cyclophosphamide (CY) is associated with potentially fatal cardiotoxicity, yet no electrocardiographic indices have been established for early detection of CY‐induced cardiomyopathy. This study aimed to determine whether corrected QT interval (QTc) prolongation can predict early onset of CY‐related cardiac dysfunction in pediatric ...
Junpei Kawamura +5 more
wiley +1 more source
Raising the Bar: Age-adjust NT-proBNP to improve specificity and reduce delay. [PDF]
Anderson LJ.
europepmc +1 more source
NT-proBNP and Myocardial Fibrosis
openaire +1 more source
Correction to ‘Increase of serum pancreatic enzymes during hospitalization for acute heart failure’
ESC Heart Failure, Volume 12, Issue 2, Page 1526-1526, April 2025.
wiley +1 more source
Objective Diffuse alveolar hemorrhage (DAH) is a life‐threatening presentation of antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Patients with AAV are at an increased risk of venous thromboembolic events (VTEs). These manifestations can co‐occur; however, the prognosis and management of these patients are poorly understood. Methods In
Elif D. Ediboglu +5 more
wiley +1 more source
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy
Early cardiac biomarker monitoring in AML induction therapy showed significantly higher hsTnT levels after daunorubicin 90 mg/m2 compared with 60 mg/m2, indicating a dose‐dependent early myocardial effect. ABSTRACT Anthracyclines are an essential component of induction therapy for acute myeloid leukemia (AML), but their optimal dosing and the ...
Stefan Markus Dendorfer +44 more
wiley +1 more source

